4//SEC Filing
Venrock Management VII, LLC 4
Accession 0001209191-21-042724
CIK 0001662244other
Filed
Jun 22, 8:00 PM ET
Accepted
Jun 23, 4:08 PM ET
Size
13.2 KB
Accession
0001209191-21-042724
Insider Transaction Report
Form 4
Venrock Associates VII, L.P.
10% Owner
Transactions
- Conversion
Common Stock
2021-06-22+3,259,025→ 3,259,025 total(indirect: By Funds) - Conversion
Series C Convertible Preferred Stock
2021-06-22−1,109,368→ 0 total→ Common Stock (325,442 underlying) - Conversion
Series B Convertible Preferred Stock
2021-06-22−10,000,000→ 0 total→ Common Stock (2,933,583 underlying)
Venrock Partners VII, L.P.
10% Owner
Transactions
- Conversion
Common Stock
2021-06-22+3,259,025→ 3,259,025 total(indirect: By Funds) - Conversion
Series C Convertible Preferred Stock
2021-06-22−1,109,368→ 0 total→ Common Stock (325,442 underlying) - Conversion
Series B Convertible Preferred Stock
2021-06-22−10,000,000→ 0 total→ Common Stock (2,933,583 underlying)
Venrock Management VII, LLC
10% Owner
Transactions
- Conversion
Series C Convertible Preferred Stock
2021-06-22−1,109,368→ 0 total→ Common Stock (325,442 underlying) - Conversion
Series B Convertible Preferred Stock
2021-06-22−10,000,000→ 0 total→ Common Stock (2,933,583 underlying) - Conversion
Common Stock
2021-06-22+3,259,025→ 3,259,025 total(indirect: By Funds)
Footnotes (2)
- [F1]Each share of Series B Convertible Preferred Stock and Series C Convertible Preferred Stock converted into shares of Common Stock at a ratio of 1:3.4088 upon completion of the Issuer's initial public offering. The shares have no expiration date.
- [F2]Consists of 3,009,710 shares of Common Stock held by Venrock Associates VII, L.P. ("VA VII") and 249,315 shares of Common Stock held by Venrock Partners VII, L.P. ("VP VII"). Venrock Management VII, LLC ("VM VII") is the sole general partner of VA VII and VP VII and may be deemed to beneficially own these shares and expressly disclaims beneficial ownership over all shares held by VA VII and VP VII except to the extent of its indirect pecuniary interest therein.
Documents
Issuer
Cyteir Therapeutics, Inc.
CIK 0001662244
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001614686
Filing Metadata
- Form type
- 4
- Filed
- Jun 22, 8:00 PM ET
- Accepted
- Jun 23, 4:08 PM ET
- Size
- 13.2 KB